Cargando…

Assessing the Influence of Propylthiouracil and Phenytoin on the Metabolomes of the Thyroid, Liver, and Plasma in Rats

The thyroid hormones (THs) regulate various physiological mechanisms in mammals, such as cellular metabolism, cell structure, and membrane transport. The therapeutic drugs propylthiouracil (PTU) and phenytoin are known to induce hypothyroidism and decrease blood thyroid hormone levels. To analyze th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhipeng, Haange, Sven-Bastiaan, Haake, Volker, Huisinga, Maike, Kamp, Hennicke, Buesen, Roland, Schubert, Kristin, Canzler, Sebastian, Hackermüller, Jörg, Rolle-Kampczyk, Ulrike, von Bergen, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383188/
https://www.ncbi.nlm.nih.gov/pubmed/37512556
http://dx.doi.org/10.3390/metabo13070847
_version_ 1785080846052491264
author Wang, Zhipeng
Haange, Sven-Bastiaan
Haake, Volker
Huisinga, Maike
Kamp, Hennicke
Buesen, Roland
Schubert, Kristin
Canzler, Sebastian
Hackermüller, Jörg
Rolle-Kampczyk, Ulrike
von Bergen, Martin
author_facet Wang, Zhipeng
Haange, Sven-Bastiaan
Haake, Volker
Huisinga, Maike
Kamp, Hennicke
Buesen, Roland
Schubert, Kristin
Canzler, Sebastian
Hackermüller, Jörg
Rolle-Kampczyk, Ulrike
von Bergen, Martin
author_sort Wang, Zhipeng
collection PubMed
description The thyroid hormones (THs) regulate various physiological mechanisms in mammals, such as cellular metabolism, cell structure, and membrane transport. The therapeutic drugs propylthiouracil (PTU) and phenytoin are known to induce hypothyroidism and decrease blood thyroid hormone levels. To analyze the impact of these two drugs on systemic metabolism, we focused on metabolic changes after treatment. Therefore, in a rat model, the metabolome of thyroid and liver tissue as well as from the blood plasma, after 2-week and 4-week administration of the drugs and after a following 2-week recovery phase, was investigated using targeted LC-MS/MS and GC-MS. Both drugs were tested at a low dose and a high dose. We observed decreases in THs plasma levels, and higher doses of the drugs were associated with a high decrease in TH levels. PTU administration had a more pronounced effect on TH levels than phenytoin. Both drugs had little or no influence on the metabolomes at low doses. Only PTU exhibited apparent metabolome alterations at high doses, especially concerning lipids. In plasma, acylcarnitines and triglycerides were detected at decreased levels than in the controls after 2- and 4-week exposure to the drug, while sphingomyelins and phosphatidylcholines were observed at increased levels. Interestingly, in the thyroid tissue, triglycerides were observed at increased concentrations in the 2-week exposure group to PTU, which was not observed in the 4-week exposure group and in the 4-week exposure group followed by the 2-week recovery group, suggesting an adaptation by the thyroid tissue. In the liver, no metabolites were found to have significantly changed. After the recovery phase, the thyroid, liver, and plasma metabolomic profiles showed little or no differences from the controls. In conclusion, although there were significant changes observed in several plasma metabolites in PTU/Phenytoin exposure groups, this study found that only PTU exposure led to adaptation-dependent changes in thyroid metabolites but did not affect hepatic metabolites.
format Online
Article
Text
id pubmed-10383188
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103831882023-07-30 Assessing the Influence of Propylthiouracil and Phenytoin on the Metabolomes of the Thyroid, Liver, and Plasma in Rats Wang, Zhipeng Haange, Sven-Bastiaan Haake, Volker Huisinga, Maike Kamp, Hennicke Buesen, Roland Schubert, Kristin Canzler, Sebastian Hackermüller, Jörg Rolle-Kampczyk, Ulrike von Bergen, Martin Metabolites Article The thyroid hormones (THs) regulate various physiological mechanisms in mammals, such as cellular metabolism, cell structure, and membrane transport. The therapeutic drugs propylthiouracil (PTU) and phenytoin are known to induce hypothyroidism and decrease blood thyroid hormone levels. To analyze the impact of these two drugs on systemic metabolism, we focused on metabolic changes after treatment. Therefore, in a rat model, the metabolome of thyroid and liver tissue as well as from the blood plasma, after 2-week and 4-week administration of the drugs and after a following 2-week recovery phase, was investigated using targeted LC-MS/MS and GC-MS. Both drugs were tested at a low dose and a high dose. We observed decreases in THs plasma levels, and higher doses of the drugs were associated with a high decrease in TH levels. PTU administration had a more pronounced effect on TH levels than phenytoin. Both drugs had little or no influence on the metabolomes at low doses. Only PTU exhibited apparent metabolome alterations at high doses, especially concerning lipids. In plasma, acylcarnitines and triglycerides were detected at decreased levels than in the controls after 2- and 4-week exposure to the drug, while sphingomyelins and phosphatidylcholines were observed at increased levels. Interestingly, in the thyroid tissue, triglycerides were observed at increased concentrations in the 2-week exposure group to PTU, which was not observed in the 4-week exposure group and in the 4-week exposure group followed by the 2-week recovery group, suggesting an adaptation by the thyroid tissue. In the liver, no metabolites were found to have significantly changed. After the recovery phase, the thyroid, liver, and plasma metabolomic profiles showed little or no differences from the controls. In conclusion, although there were significant changes observed in several plasma metabolites in PTU/Phenytoin exposure groups, this study found that only PTU exposure led to adaptation-dependent changes in thyroid metabolites but did not affect hepatic metabolites. MDPI 2023-07-14 /pmc/articles/PMC10383188/ /pubmed/37512556 http://dx.doi.org/10.3390/metabo13070847 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Zhipeng
Haange, Sven-Bastiaan
Haake, Volker
Huisinga, Maike
Kamp, Hennicke
Buesen, Roland
Schubert, Kristin
Canzler, Sebastian
Hackermüller, Jörg
Rolle-Kampczyk, Ulrike
von Bergen, Martin
Assessing the Influence of Propylthiouracil and Phenytoin on the Metabolomes of the Thyroid, Liver, and Plasma in Rats
title Assessing the Influence of Propylthiouracil and Phenytoin on the Metabolomes of the Thyroid, Liver, and Plasma in Rats
title_full Assessing the Influence of Propylthiouracil and Phenytoin on the Metabolomes of the Thyroid, Liver, and Plasma in Rats
title_fullStr Assessing the Influence of Propylthiouracil and Phenytoin on the Metabolomes of the Thyroid, Liver, and Plasma in Rats
title_full_unstemmed Assessing the Influence of Propylthiouracil and Phenytoin on the Metabolomes of the Thyroid, Liver, and Plasma in Rats
title_short Assessing the Influence of Propylthiouracil and Phenytoin on the Metabolomes of the Thyroid, Liver, and Plasma in Rats
title_sort assessing the influence of propylthiouracil and phenytoin on the metabolomes of the thyroid, liver, and plasma in rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383188/
https://www.ncbi.nlm.nih.gov/pubmed/37512556
http://dx.doi.org/10.3390/metabo13070847
work_keys_str_mv AT wangzhipeng assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT haangesvenbastiaan assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT haakevolker assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT huisingamaike assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT kamphennicke assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT buesenroland assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT schubertkristin assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT canzlersebastian assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT hackermullerjorg assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT rollekampczykulrike assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats
AT vonbergenmartin assessingtheinfluenceofpropylthiouracilandphenytoinonthemetabolomesofthethyroidliverandplasmainrats